-
1
-
-
84870568785
-
Circulating fibroblast growth factors as metabolic regulators-a critical appraisal
-
Angelin B., Larsson T.E., Rudling M. Circulating fibroblast growth factors as metabolic regulators-a critical appraisal. Cell Metabolism 2012, 16:693-705.
-
(2012)
Cell Metabolism
, vol.16
, pp. 693-705
-
-
Angelin, B.1
Larsson, T.E.2
Rudling, M.3
-
2
-
-
84865731947
-
Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21
-
Iglesias P., Selgas R., Romero S., Diez J.J. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21. European Journal of Endocrinology 2012, 167:301-309.
-
(2012)
European Journal of Endocrinology
, vol.167
, pp. 301-309
-
-
Iglesias, P.1
Selgas, R.2
Romero, S.3
Diez, J.J.4
-
3
-
-
20444435873
-
FGF-21 as a novel metabolic regulator
-
Kharitonenkov A., Shiyanova T.L., Koester A., Ford A.M., Micanovic R., Galbreath E.J., et al. FGF-21 as a novel metabolic regulator. Journal of Clinical Investigation 2005, 115:1627-1635.
-
(2005)
Journal of Clinical Investigation
, vol.115
, pp. 1627-1635
-
-
Kharitonenkov, A.1
Shiyanova, T.L.2
Koester, A.3
Ford, A.M.4
Micanovic, R.5
Galbreath, E.J.6
-
4
-
-
57349098220
-
Fibroblast growth factor 21 corrects obesity in mice
-
Coskun T., Bina H.A., Schneider M.A., Dunbar J.D., Hu C.C., Chen Y., et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 2008, 149:6018-6027.
-
(2008)
Endocrinology
, vol.149
, pp. 6018-6027
-
-
Coskun, T.1
Bina, H.A.2
Schneider, M.A.3
Dunbar, J.D.4
Hu, C.C.5
Chen, Y.6
-
5
-
-
69249093921
-
Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity
-
Berglund E.D., Li C.Y., Bina H.A., Lynes S.E., Michael M.D., Shanafelt A.B., et al. Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity. Endocrinology 2009, 150:4084-4093.
-
(2009)
Endocrinology
, vol.150
, pp. 4084-4093
-
-
Berglund, E.D.1
Li, C.Y.2
Bina, H.A.3
Lynes, S.E.4
Michael, M.D.5
Shanafelt, A.B.6
-
6
-
-
84859531060
-
Relationship of serum fibroblast growth factor 21 with abnormal glucose metabolism and insulin resistance: the Baltimore Longitudinal Study of Aging
-
Semba R.D., Sun K., Egan J.M., Crasto C., Carlson O.D., Ferrucci L. Relationship of serum fibroblast growth factor 21 with abnormal glucose metabolism and insulin resistance: the Baltimore Longitudinal Study of Aging. Journal of Clinical Endocrinology and Metabolism 2012, 97:1375-1382.
-
(2012)
Journal of Clinical Endocrinology and Metabolism
, vol.97
, pp. 1375-1382
-
-
Semba, R.D.1
Sun, K.2
Egan, J.M.3
Crasto, C.4
Carlson, O.D.5
Ferrucci, L.6
-
7
-
-
84872009444
-
Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians
-
Bobbert T., Schwarz F., Fischer-Rosinsky A., Pfeiffer A.F., Mohlig M., Mai K., et al. Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians. Diabetes Care 2013, 36:145-149.
-
(2013)
Diabetes Care
, vol.36
, pp. 145-149
-
-
Bobbert, T.1
Schwarz, F.2
Fischer-Rosinsky, A.3
Pfeiffer, A.F.4
Mohlig, M.5
Mai, K.6
-
8
-
-
84883118811
-
Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
-
Shen Y., Ma X., Zhou J., Pan X., Hao Y., Zhou M., et al. Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease. Cardiovascular Diabetology 2013, 12:124.
-
(2013)
Cardiovascular Diabetology
, vol.12
, pp. 124
-
-
Shen, Y.1
Ma, X.2
Zhou, J.3
Pan, X.4
Hao, Y.5
Zhou, M.6
-
9
-
-
68149091653
-
Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance
-
Chavez A.O., Molina-Carrion M., Abdul-Ghani M.A., Folli F., Defronzo R.A., Tripathy D. Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance. Diabetes Care 2009, 32:1542-1546.
-
(2009)
Diabetes Care
, vol.32
, pp. 1542-1546
-
-
Chavez, A.O.1
Molina-Carrion, M.2
Abdul-Ghani, M.A.3
Folli, F.4
Defronzo, R.A.5
Tripathy, D.6
-
10
-
-
77955474305
-
Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease
-
Dushay J., Chui P.C., Gopalakrishnan G.S., Varela-Rey M., Crawley M., Fisher F.M., et al. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology 2010, 139:456-463.
-
(2010)
Gastroenterology
, vol.139
, pp. 456-463
-
-
Dushay, J.1
Chui, P.C.2
Gopalakrishnan, G.S.3
Varela-Rey, M.4
Crawley, M.5
Fisher, F.M.6
-
11
-
-
49449092403
-
Identification and characterization of metabolically benign obesity in humans
-
Stefan N., Kantartzis K., Machann J., Schick F., Thamer C., Rittig K., et al. Identification and characterization of metabolically benign obesity in humans. Archives of Internal Medicine 2008, 168:1609-1616.
-
(2008)
Archives of Internal Medicine
, vol.168
, pp. 1609-1616
-
-
Stefan, N.1
Kantartzis, K.2
Machann, J.3
Schick, F.4
Thamer, C.5
Rittig, K.6
-
12
-
-
80052840577
-
The metabolically benign and malignant fatty liver
-
Stefan N., Haring H.U. The metabolically benign and malignant fatty liver. Diabetes 2011, 60:2011-2017.
-
(2011)
Diabetes
, vol.60
, pp. 2011-2017
-
-
Stefan, N.1
Haring, H.U.2
-
13
-
-
84898915968
-
Metabolic signatures of cultured human adipocytes from metabolically healthy versus unhealthy obese individuals
-
Bohm A., Halama A., Meile T., Zdichavsky M., Lehmann R., Weigert C., et al. Metabolic signatures of cultured human adipocytes from metabolically healthy versus unhealthy obese individuals. PLoS One 2014, 9:e93148.
-
(2014)
PLoS One
, vol.9
, pp. e93148
-
-
Bohm, A.1
Halama, A.2
Meile, T.3
Zdichavsky, M.4
Lehmann, R.5
Weigert, C.6
-
14
-
-
0032964594
-
Evidence for a local renin angiotensin system in primary cultured human preadipocytes
-
Schling P., Mallow H., Trindl A., Loffler G. Evidence for a local renin angiotensin system in primary cultured human preadipocytes. International Journal of Obesity and Related Metabolic Disorders 1999, 23:336-341.
-
(1999)
International Journal of Obesity and Related Metabolic Disorders
, vol.23
, pp. 336-341
-
-
Schling, P.1
Mallow, H.2
Trindl, A.3
Loffler, G.4
-
15
-
-
0018630146
-
Corticosteroid-dependent differentiation of human marrow preadipocytes in vitro
-
Greenberger J.S. Corticosteroid-dependent differentiation of human marrow preadipocytes in vitro. In Vitro 1979, 15:823-828.
-
(1979)
In Vitro
, vol.15
, pp. 823-828
-
-
Greenberger, J.S.1
-
16
-
-
0026793195
-
Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O
-
Ramirez-Zacarias J.L., Castro-Munozledo F., Kuri-Harcuch W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry 1992, 97:493-497.
-
(1992)
Histochemistry
, vol.97
, pp. 493-497
-
-
Ramirez-Zacarias, J.L.1
Castro-Munozledo, F.2
Kuri-Harcuch, W.3
-
17
-
-
33747839466
-
CARMAweb: comprehensive R- and bioconductor-based web service for microarray data analysis
-
Rainer J., Sanchez-Cabo F., Stocker G., Sturn A., Trajanoski Z. CARMAweb: comprehensive R- and bioconductor-based web service for microarray data analysis. Nucleic Acids Research 2006, 34:W498-W503.
-
(2006)
Nucleic Acids Research
, vol.34
, pp. W498-W503
-
-
Rainer, J.1
Sanchez-Cabo, F.2
Stocker, G.3
Sturn, A.4
Trajanoski, Z.5
-
18
-
-
84883481988
-
The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes
-
Gaich G., Chien J.Y., Fu H., Glass L.C., Deeg M.A., Holland W.L., et al. The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metabolism 2013, 18:333-340.
-
(2013)
Cell Metabolism
, vol.18
, pp. 333-340
-
-
Gaich, G.1
Chien, J.Y.2
Fu, H.3
Glass, L.C.4
Deeg, M.A.5
Holland, W.L.6
-
19
-
-
43549110007
-
FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity
-
Arner P., Pettersson A., Mitchell P.J., Dunbar J.D., Kharitonenkov A., Ryden M. FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity. FEBS Letters 2008, 582:1725-1730.
-
(2008)
FEBS Letters
, vol.582
, pp. 1725-1730
-
-
Arner, P.1
Pettersson, A.2
Mitchell, P.J.3
Dunbar, J.D.4
Kharitonenkov, A.5
Ryden, M.6
-
20
-
-
79952120254
-
Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity
-
Mashili F.L., Austin R.L., Deshmukh A.S., Fritz T., Caidahl K., Bergdahl K., et al. Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. Diabetes/Metabolism Research and Reviews 2011, 27:286-297.
-
(2011)
Diabetes/Metabolism Research and Reviews
, vol.27
, pp. 286-297
-
-
Mashili, F.L.1
Austin, R.L.2
Deshmukh, A.S.3
Fritz, T.4
Caidahl, K.5
Bergdahl, K.6
-
21
-
-
84863012022
-
FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis
-
Fisher F.M., Kleiner S., Douris N., Fox E.C., Mepani R.J., Verdeguer F., et al. FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis. Genes & Development 2012, 26:271-281.
-
(2012)
Genes & Development
, vol.26
, pp. 271-281
-
-
Fisher, F.M.1
Kleiner, S.2
Douris, N.3
Fox, E.C.4
Mepani, R.J.5
Verdeguer, F.6
-
22
-
-
77955434383
-
Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway
-
Chau M.D., Gao J., Yang Q., Wu Z., Gromada J. Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:12553-12558.
-
(2010)
Proceedings of the National Academy of Sciences of the United States of America
, vol.107
, pp. 12553-12558
-
-
Chau, M.D.1
Gao, J.2
Yang, Q.3
Wu, Z.4
Gromada, J.5
-
23
-
-
20444440341
-
Adiponectin: an adipokine linking adipocytes and type 2 diabetes in humans
-
Hara K., Yamauchi T., Kadowaki T. Adiponectin: an adipokine linking adipocytes and type 2 diabetes in humans. Current Diabetes Reports 2005, 5:136-140.
-
(2005)
Current Diabetes Reports
, vol.5
, pp. 136-140
-
-
Hara, K.1
Yamauchi, T.2
Kadowaki, T.3
-
24
-
-
84907610526
-
Cardiorespiratory fitness and visceral fat are key determinants of serum fibroblast growth factor 21 concentration in Japanese men
-
Taniguchi H., Tanisawa K., Sun X., Cao Z.B., Oshima S., Ise R., et al. Cardiorespiratory fitness and visceral fat are key determinants of serum fibroblast growth factor 21 concentration in Japanese men. Journal of Clinical Endocrinology and Metabolism 2014, 99:E1877-E1884.
-
(2014)
Journal of Clinical Endocrinology and Metabolism
, vol.99
, pp. E1877-E1884
-
-
Taniguchi, H.1
Tanisawa, K.2
Sun, X.3
Cao, Z.B.4
Oshima, S.5
Ise, R.6
-
25
-
-
84890565195
-
Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure
-
Mutanen A., Heikkila P., Lohi J., Raivio T., Jalanko H., Pakarinen M.P. Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure. Journal of Hepatology 2014, 60:183-190.
-
(2014)
Journal of Hepatology
, vol.60
, pp. 183-190
-
-
Mutanen, A.1
Heikkila, P.2
Lohi, J.3
Raivio, T.4
Jalanko, H.5
Pakarinen, M.P.6
-
26
-
-
84879938853
-
Circulating levels of FGF-21 in obese youth: associations with liver fat content and markers of liver damage
-
Giannini C., Feldstein A.E., Santoro N., Kim G., Kursawe R., Pierpont B., et al. Circulating levels of FGF-21 in obese youth: associations with liver fat content and markers of liver damage. Journal of Clinical Endocrinology and Metabolism 2013, 98:2993-3000.
-
(2013)
Journal of Clinical Endocrinology and Metabolism
, vol.98
, pp. 2993-3000
-
-
Giannini, C.1
Feldstein, A.E.2
Santoro, N.3
Kim, G.4
Kursawe, R.5
Pierpont, B.6
-
27
-
-
84889591200
-
Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status
-
Lee Y., Lim S., Hong E.S., Kim J.H., Moon M.K., Chun E.J., et al. Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status. Clinical Endocrinology (Oxford) 2014, 80:57-64.
-
(2014)
Clinical Endocrinology (Oxford)
, vol.80
, pp. 57-64
-
-
Lee, Y.1
Lim, S.2
Hong, E.S.3
Kim, J.H.4
Moon, M.K.5
Chun, E.J.6
-
28
-
-
84861996283
-
Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis
-
Reinehr T., Woelfle J., Wunsch R., Roth C.L. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis. Journal of Clinical Endocrinology and Metabolism 2012, 97:2143-2150.
-
(2012)
Journal of Clinical Endocrinology and Metabolism
, vol.97
, pp. 2143-2150
-
-
Reinehr, T.1
Woelfle, J.2
Wunsch, R.3
Roth, C.L.4
-
29
-
-
80755168936
-
Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity
-
Tan B.K., Hallschmid M., Adya R., Kern W., Lehnert H., Randeva H.S. Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity. Diabetes 2011, 60:2758-2762.
-
(2011)
Diabetes
, vol.60
, pp. 2758-2762
-
-
Tan, B.K.1
Hallschmid, M.2
Adya, R.3
Kern, W.4
Lehnert, H.5
Randeva, H.S.6
-
30
-
-
48349146527
-
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
-
Zhang X., Yeung D.C., Karpisek M., Stejskal D., Zhou Z.G., Liu F., et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 2008, 57:1246-1253.
-
(2008)
Diabetes
, vol.57
, pp. 1246-1253
-
-
Zhang, X.1
Yeung, D.C.2
Karpisek, M.3
Stejskal, D.4
Zhou, Z.G.5
Liu, F.6
-
31
-
-
77956276954
-
Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels
-
Cuevas-Ramos D., Almeda-Valdes P., Gomez-Perez F.J., Meza-Arana C.E., Cruz-Bautista I., Arellano-Campos O., et al. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels. European Journal of Endocrinology 2010, 163:469-477.
-
(2010)
European Journal of Endocrinology
, vol.163
, pp. 469-477
-
-
Cuevas-Ramos, D.1
Almeda-Valdes, P.2
Gomez-Perez, F.J.3
Meza-Arana, C.E.4
Cruz-Bautista, I.5
Arellano-Campos, O.6
-
32
-
-
51649118899
-
Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa
-
Dostalova I., Kavalkova P., Haluzikova D., Lacinova Z., Mraz M., Papezova H., et al. Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 2008, 93:3627-3632.
-
(2008)
Journal of Clinical Endocrinology and Metabolism
, vol.93
, pp. 3627-3632
-
-
Dostalova, I.1
Kavalkova, P.2
Haluzikova, D.3
Lacinova, Z.4
Mraz, M.5
Papezova, H.6
-
33
-
-
84881555231
-
Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects
-
Haluzikova D., Lacinova Z., Kavalkova P., Drapalova J., Krizova J., Bartlova M., et al. Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects. Obesity. (Silver. Spring) 2013, 21:1335-1342.
-
(2013)
Obesity. (Silver. Spring)
, vol.21
, pp. 1335-1342
-
-
Haluzikova, D.1
Lacinova, Z.2
Kavalkova, P.3
Drapalova, J.4
Krizova, J.5
Bartlova, M.6
-
34
-
-
84899981949
-
Evaluation of total adiponectin, adipocyte fatty acid binding protein and fibroblast growth factor 21 levels in individuals with metabolic syndrome
-
Novotny D., Vaverkova H., Karasek D., Lukes J., Slavik L., Malina P., et al. Evaluation of total adiponectin, adipocyte fatty acid binding protein and fibroblast growth factor 21 levels in individuals with metabolic syndrome. Physiological Research 2014, 63:219-228.
-
(2014)
Physiological Research
, vol.63
, pp. 219-228
-
-
Novotny, D.1
Vaverkova, H.2
Karasek, D.3
Lukes, J.4
Slavik, L.5
Malina, P.6
-
35
-
-
84894157731
-
Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history
-
Wang D., Zhu W., Li J., An C., Wang Z. Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history. PLoS One 2013, 8:e81190.
-
(2013)
PLoS One
, vol.8
, pp. e81190
-
-
Wang, D.1
Zhu, W.2
Li, J.3
An, C.4
Wang, Z.5
-
36
-
-
84874903440
-
Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319
-
Kharitonenkov A., Beals J.M., Micanovic R., Strifler B.A., Rathnachalam R., Wroblewski V.J., et al. Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319. PLoS One 2013, 8:e58575.
-
(2013)
PLoS One
, vol.8
, pp. e58575
-
-
Kharitonenkov, A.1
Beals, J.M.2
Micanovic, R.3
Strifler, B.A.4
Rathnachalam, R.5
Wroblewski, V.J.6
-
37
-
-
4243645912
-
Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization
-
Combs T.P., Wagner J.A., Berger J., Doebber T., Wang W.J., Zhang B.B., et al. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 2002, 143:998-1007.
-
(2002)
Endocrinology
, vol.143
, pp. 998-1007
-
-
Combs, T.P.1
Wagner, J.A.2
Berger, J.3
Doebber, T.4
Wang, W.J.5
Zhang, B.B.6
-
38
-
-
0035462629
-
PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein
-
Maeda N., Takahashi M., Funahashi T., Kihara S., Nishizawa H., Kishida K., et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001, 50:2094-2099.
-
(2001)
Diabetes
, vol.50
, pp. 2094-2099
-
-
Maeda, N.1
Takahashi, M.2
Funahashi, T.3
Kihara, S.4
Nishizawa, H.5
Kishida, K.6
-
39
-
-
0037459090
-
Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes
-
Fasshauer M., Kralisch S., Klier M., Lossner U., Bluher M., Klein J., et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 2003, 301:1045-1050.
-
(2003)
Biochemical and Biophysical Research Communications
, vol.301
, pp. 1045-1050
-
-
Fasshauer, M.1
Kralisch, S.2
Klier, M.3
Lossner, U.4
Bluher, M.5
Klein, J.6
-
40
-
-
3042678193
-
High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator
-
Sopasakis V.R., Sandqvist M., Gustafson B., Hammarstedt A., Schmelz M., Yang X., et al. High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obesity Research 2004, 12:454-460.
-
(2004)
Obesity Research
, vol.12
, pp. 454-460
-
-
Sopasakis, V.R.1
Sandqvist, M.2
Gustafson, B.3
Hammarstedt, A.4
Schmelz, M.5
Yang, X.6
-
41
-
-
84884500386
-
Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications
-
Stefan N., Haring H.U., Hu F.B., Schulze M.B. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes & Endocrinology 2013, 1:152-162.
-
(2013)
Lancet Diabetes & Endocrinology
, vol.1
, pp. 152-162
-
-
Stefan, N.1
Haring, H.U.2
Hu, F.B.3
Schulze, M.B.4
-
42
-
-
77957359658
-
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
-
Li H., Fang Q., Gao F., Fan J., Zhou J., Wang X., et al. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. Journal of Hepatology 2010, 53:934-940.
-
(2010)
Journal of Hepatology
, vol.53
, pp. 934-940
-
-
Li, H.1
Fang, Q.2
Gao, F.3
Fan, J.4
Zhou, J.5
Wang, X.6
-
43
-
-
85006619329
-
Adiponectin isoforms differentially affect gene expression and the lipidome of primary human hepatocytes
-
Wanninger J., Liebisch G., Eisinger K., Neumeier M., Aslanidis C., Voggenreiter L., et al. Adiponectin isoforms differentially affect gene expression and the lipidome of primary human hepatocytes. Metabolites 2014, 4:394-407.
-
(2014)
Metabolites
, vol.4
, pp. 394-407
-
-
Wanninger, J.1
Liebisch, G.2
Eisinger, K.3
Neumeier, M.4
Aslanidis, C.5
Voggenreiter, L.6
-
44
-
-
84869051421
-
Liraglutide increases FGF-21 activity and insulin sensitivity in high fat diet and adiponectin knockdown induced insulin resistance
-
Yang M., Zhang L., Wang C., Liu H., Boden G., Yang G., et al. Liraglutide increases FGF-21 activity and insulin sensitivity in high fat diet and adiponectin knockdown induced insulin resistance. PLoS One 2012, 7:e48392.
-
(2012)
PLoS One
, vol.7
, pp. e48392
-
-
Yang, M.1
Zhang, L.2
Wang, C.3
Liu, H.4
Boden, G.5
Yang, G.6
|